“I am proud of the Biological Institute staff, who have made a major breakthrough,” Defense Minister Naftali Bennett said.
The Israel Institute for Biological Research (IIBR) has completed the development phase of COVID-19 antibody or passive vaccine, according to a statement by the Defense Ministry.
Defense Minister Naftali Bennett visited the Ness Ziona-based lab on Monday and was briefed by the research team, who revealed a breakthrough antibody that attacks the virus and neutralizes it in the body.
IIBR is now working to patent its antibody and secure a contract for its commercial development. All legal procedures will be coordinated with the Defense Ministry.
“I am proud of the Biological Institute staff, who have made a major breakthrough,” Bennett said Monday. “The Jewish creativity and ingenuity brought about this amazing achievement.
”Last month, IIBR announced that it had begun testing its antibody-based vaccine prototype on rodents.IIBR is also involved in plasma collection from people who have recovered from infection with the new coronavirus, in the hope that this might help research.















